Lack of muscle stem cell proliferation and myocellular hypertrophy in sIBM patients following blood-flow restricted resistance training

• Published in: Neuromuscular disorders : NMD Vol. 32; no. 6; pp. 493 - 502
• Main Authors: Jensen, Kasper Yde, Nielsen, Jakob Lindberg, Schrøder, Henrik Daa, Jacobsen, Mikkel, Boyle, Eleanor, Jørgensen, Anders Nørkær, Bech, Rune Dueholm, Frandsen, Ulrik, Aagaard, Per, Diederichsen, Louise Pyndt
• Format: Journal Article
• Language: English
• Published: England Elsevier B.V 01-06-2022
• Subjects: Capillaries; Exercise; Myogenic plasticity; Myonuclei; Myositis; Satellite cells; Myogenic plasticity; Myositis; Satellite cells; Exercise; Capillaries; Myonuclei
• ISSN: 0960-8966; 1873-2364
• DOI: 10.1016/j.nmd.2022.04.006

•12 weeks of BFR training did not boost satellite cell number in sIBM patients.•12 weeks of BFR training did not increase myofibre CSA in sIBM patients.•12 weeks of BFR training did not affect myonuclei content in sIBM patients.
Sporadic inclusion body myositis (sIBM) is characterised by skeletal muscle inflammation, progressive muscle loss and weakness, which is largely refractory to immunosuppressive treatment. Low-load blood-flow restricted (BFR) training has been shown to evoke gains in myofibre cross sectional area (mCSA) in healthy adults. This could partially be due to the activation and integration of muscle satellite cells (SC) resulting in myonuclei addition. Consequently, this study investigated the effect of 12-weeks lower limb low-load BFR resistance training in sIBM patients on SC and myonuclei content, myofibre size and capillarization. Muscle biopsies from sIBM patients randomised to 12-weeks of low-load BFR resistance training (n = 11) or non-exercising controls (CON) (n = 9) were analysed for SC and myonuclei content, myofibre size and capillarization using three-colour immunofluorescence microscopy and computerised quantification procedures. No between-group differences (time-by-group interactions) or within-groups changes were observed for resident SCs (Pax7+/Six1+), proliferating SCs (Pax7+/ Ki67+), myonuclei (Six1+), type 1 mCSA or capillary number (CD31+). However, a time-by-group interaction for type 2 mCSA was observed (p = 0.04). Satellite cell content, myonuclei number, mCSA and capillary density remained unaffected following 12-weeks low-load BFR resistance training, indicating limited myogenic capacity and satellite cell plasticity in long-term sIBM patients.